Navigation Links
The End of the Bio-Identical Hormone Debate
Date:9/10/2009

FORT LAUDERDALE, Fla., Sept. 10 /PRNewswire/ -- Life Extension(R), the company that long ago sounded the alarm on the dangers of synthetic hormone replacement therapy for menopausal women, has published still more proof that bioidentical hormones offer a far safer treatment option.

A white paper entitled Bioidentical Hormones: Why Is There Still a Controversy, published in the October edition of Life Extension Magazine, provides compelling scientific evidence on the safety and effectiveness of bioidentical hormone therapy. This position paper strongly documents the advantages of topical bioidentical hormone creams in contrast to the known safety risks associated with orally-administered conjugated equine (horse-derived) estrogens and progestin.

Individualized topical bioidentical hormone creams are available only through select compounding pharmacies, as the FDA has caved into the powerful influence of the pharmaceutical lobby and limited the sale of estriol, which has grossly increased its price and decreased its availability.

The pharmaceutical industry has billions of dollars invested in pushing antiquated equine estrogens and non-bioidentical progestin formulations that have been repeatedly linked to toxic side effects. They have lobbied the FDA to restrict the sale of compounding estriol creams by labeling compounding pharmacies unsafe and unregulated.

The FDA approved the use of Premarin(R) (mare urine-derived estrogen) 67 years ago, but today the same drug is still being prescribed as the answer to estrogen depletion for a generation of women who are desperate for better alternatives. The science is in. The answers are clear. The time for this controversy is over.

Medical Expert Available for Media Interview on Bio-Identical Hormones

Steven V. Joyal, M.D., Vice President of Scientific Affairs at Life Extension(R), is available for interviews on the bioidentical hormone debate ... and information on the benefits of natural, estriol-based topical creams compounded by independent pharmacies.

About Life Extension

Life Extension has been researching and reporting breakthroughs in alternative medicine, nutrition, and preventive health since 1980.


'/>"/>
SOURCE Life Extension
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Warns Against Bio-Identical Hormone Therapy
2. The Truth About Bio-identical Hormone Therapy
3. Washington, DC Plastic Surgeon Mark E. Richards, M.D. Says Bio-Identical Hormone Therapy has Staggering Health Benefits that Could Change the Way We Age
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Researchers develop long-lasting growth hormone
6. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
7. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds
8. Most Women Unaware of Hormone Replacement Study
9. Survival data presented from phase II study of hormone-resistant prostate cancer patients
10. Hormone May Play Key Part in Creating Memories
11. Hormone Therapy for Prostate Cancer Linked to Heart Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: